Genix Pharmaceuticals Corporation
Genix Pharmaceuticals Corporation
Share · CA37232A1093 (OTC)
Overview
No Price
Closing Price OTC 29.01.2026: 0,01 USD
29.01.2026 21:00
Current Prices from Genix Pharmaceuticals Corporation
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
GENPF
USD
29.01.2026 21:00
0,01 USD
0,00 USD
Company Profile for Genix Pharmaceuticals Corporation Share
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with focus on nutraceuticals and pharmaceuticals in Canada. The company develops Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Renochlor, a dietary supplement to aid in the restoration of kidney health and kidney function; and Sucanon, an insulin sensitizer that lowers blood sugar by increasing the muscle, fat, and liver's sensitivity to insulin. It also markets and sells nutraceuticals and pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels, and spirulina powder, as well as eye ointments and drops. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.
AI Analysis of Genix Pharmaceuticals Corporation
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of Genix Pharmaceuticals Corporation
No AI threads available for this company yet.

Company Data

Name Genix Pharmaceuticals Corporation
Company Genix Pharmaceuticals Corporation
Website https://www.genixpharm.com
Primary Exchange OTC UTC
ISIN CA37232A1093
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Sina Salehi Pirooz
Country Canada
Currency USD
Employees -
Address 10022 – 102 Avenue, T8V 0Z7 Vancouver
IPO Date 2020-02-18

Ticker Symbols

Name Symbol
Over The Counter GENPF
More Shares
Investors who hold Genix Pharmaceuticals Corporation also have the following shares in their portfolio:
BK NOVA SCOT 22/32 MTN
BK NOVA SCOT 22/32 MTN Bond
MPLX 23/53
MPLX 23/53 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026